Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04214418
Title Study of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced Malignancies (MEKiAUTO)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Columbia University

Advanced Solid Tumor

colorectal adenocarcinoma


pancreatic adenocarcinoma


Atezolizumab + Cobimetinib + Hydroxychloroquine

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Columbia University Irving Medical Center Recruiting New York New York 10032 United States Details
Brown University Recruiting Providence Rhode Island 02912 United States Details
*Shaded cells indicate that there was no data available from for the field